
Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
Keywords: Influenza vaccine; MF59; Adjuvant; Children; Fluad®; (www.clinicaltrials.gov): NCT01346592; AE; adverse event; aTIV; adjuvanted trivalent influenza vaccine; CI; confidence interval; FAS; full analysis set; GMT; geometric mean titer; HI; hemagglutination